ACAD Competitors
ACADIA Pharmaceuticals Inc.
$18.62
-$0.79(-4.07%)
50
Overall
75
Value
9
Tech
68
Quality
Market Cap
$3.34B
Volume
2.13M
52W Range
$19.32 - $30.96
Target Price
$32.10
ACAD competitors: VNDA, BMY, PFE, JNJ, LLY. ACADIA Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ACAD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | $4.54 | $274.50M | $-3.02 | - | 37 |
| BMY Bristol-Myers Squibb Company | $56.65 | $117.62B | $6.80 | 3.34% | 55 |
| PFE Pfizer Inc. | $28.41 | $161.87B | $2.96 | 6.05% | 70 |
| JNJ Johnson & Johnson | $249.42 | $635.56B | $11.18 | 2.12% | 50 |
| LLY Eli Lilly and Company | $1182.62 | $1.11T | $36.19 | 0.57% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $18.62 | -4.1% | 2.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW